Global Blood Therapeutics' GAAP loss for 2020 was $247.553 million, down 7.2% from $266.766 million the previous year. Revenue increased multiple times to $123.803 million from $2.108 million a year earlier.
Global Blood Therapeutics' GAAP loss for 2020 was $247.553 million, down 7.2% from $266.766 million the previous year. Revenue increased multiple times to $123.803 million from $2.108 million a year earlier. 
ir.gbt.com
English (US) 